Harrow (HROW) Non-Current Deferred Tax Liability (2015 - 2020)
Harrow's (HROW) quarterly Non-Current Deferred Tax Liability came in at $274000.0 in Q4 2020, up 1.48% year-on-year from $270000.0 in Q1 2020, and up 1.48% quarter-over-quarter from $270000.0 in Q4 2019.
Harrow (HROW) Non-Current Deferred Tax Liability (2015 - 2020) Analysis & Trends
Harrow's Non-Current Deferred Tax Liability history runs 5 years deep, the most recent figure standing at $274000.0 for Q4 2020.
- On a quarterly basis, Non-Current Deferred Tax Liability rose 1.48% year-over-year to $274000.0 in Q4 2020; TTM through Dec 2020 was $274000.0, a 1.48% increase from a year earlier, with the FY2020 full-year figure at $274000.0, up 1.48% from the prior year.
- Non-Current Deferred Tax Liability rose to $274000.0 in Q4 2020 per HROW's latest filing, from $270000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $1.0 million in Q1 2016 and bottomed at $270000.0 in Q4 2019.
- The 4-year median for Non-Current Deferred Tax Liability is $908000.0 (2017), against an average of $806777.8.
- Across the five-year window, Non-Current Deferred Tax Liability slipped 18.62% in 2017 and gained 1.48% in 2020, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $936000.0 in 2016, then dropped by 8.97% to $852000.0 in 2017, then sank by 68.31% to $270000.0 in 2019, then climbed by 1.48% to $274000.0 in 2020.
- Per Business Quant, the three latest HROW Non-Current Deferred Tax Liability figures stand at $274000.0 (Q4 2020), $270000.0 (Q4 2019), and $852000.0 (Q3 2017).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 274,000.00 |
| Dec 31, 2020 | 274,000.00 |
| Dec 31, 2019 | 270,000.00 |
| Dec 31, 2019 | 270,000.00 |
| Sep 30, 2017 | 852,000.00 |
| Sep 30, 2017 | 852,000.00 |
| Jun 30, 2017 | 880,000.00 |
| Jun 30, 2017 | 880,000.00 |
| Mar 31, 2017 | 908,000.00 |
| Mar 31, 2017 | 908,000.00 |
| Dec 31, 2016 | 936,000.00 |
| Dec 31, 2016 | 936,000.00 |
| Sep 30, 2016 | 1.05 Mn |
| Sep 30, 2016 | 1.05 Mn |
| Jun 30, 2016 | 1.05 Mn |
| Jun 30, 2016 | 1.05 Mn |
| Mar 31, 2016 | 1.05 Mn |
| Mar 31, 2016 | 1.05 Mn |
| Dec 31, 2015 | 1.05 Mn |
| Dec 31, 2015 | 1.05 Mn |